Growth Hormone Market Overview
The Global Growth Hormone Market is expected to reach USD 5,800 Million by 2029, growing at a 7.60% CAGR between 2022 and 2029. The global market is being bolstered by a surge in initiatives being undertaken by government bodies as well as private firms to raise public awareness about GH deficiencies and growth hormone treatment, which could result in significant market growth. Furthermore, Norditropin has established itself as a leading brand in the global human growth hormone market.
When it comes to rare diseases like growth disorders, raising awareness is critical. If there is a lack of awareness, it is more likely to go unnoticed and go undiagnosed. There is a scarcity of research on the fundamental causes of growth problems and their progression among growth disorders. Most underdeveloped and developing countries have long had these conditions misdiagnosed or undiagnosed. However, the situation has shifted in recent decades. Several awareness initiatives have been launched to raise awareness about the development of children.
Report Includes
An overview of the global Growth Hormone market, and related technologies and developments. Analyses of global market trends, with historical data from 2018, 2023, and 2020 estimates and projections of CAGRs through 2029. It also includes breakdowns of the overall Growth Hormone market along with various segments, and by geographic region. Analysis of the stakeholder value chain in the Growth Hormone market and comprehensive profiles of leading companies in the industry
Report Scope
Human Growth Hormone Market COVID-19 Analysis:
The COVID-19 outbreak has had a negative impact on the market as well. Following the World Health Organization's designation of COVID-19 as a pandemic, countries all over the world enacted state-wide lockdowns to enforce social separation as a preventative measure. This caused disruption, limitations, problems, and changes in every industry sector. Similarly, the pandemic affected the Growth Hormone industry.
Following the COVID-19 outbreak, the emphasis has shifted to the rapid development of affordable and effective drugs, with the pandemic shedding light on healthcare disparities. The demand for real-world evidence has increased significantly due to the accelerated drug development rate, with major companies now opting for remote monitoring as well as source document verification (SDV), ensuring that patients can benefit despite the novel coronavirus and the resulting lockdown. While SARS-CoV-2 is the focus of healthcare, growth hormone deficiency is still a major concern around the world. As a result, research is being conducted to better understand the significance of growth hormone drugs and to broaden their application scope. In the post-pandemic era, growth in the pediatric growth hormone market size has also been favorable.
The report forecasts the size of the Growth Hormone market for components from 2022 through 2029
The Executive Summary provides a snapshot of the key findings of the report. The introduction chapter includes the research scope, market segmentation, research methodology, and definitions and assumptions. It involves extremely rigorous scientific methods, tools, and techniques to estimate the market size. Exhaustive secondary research is being carried out to collect information related to the market, the parent market, and the peer market. Primary research is undertaken to validate the assumptions, findings, and sizing with the industry experts professionals across the value chain of the market. Both top-down and bottom-up approaches are employed to estimate the complete market size.
The chapter on market dynamics includes market drivers, restraints, and opportunities which helps familiarise with market potential and upcoming opportunities. The chapter on key insights includes emerging trends from major countries, the latest technological advancement, regulatory landscape, SWOT analysis, and Porter five forces analysis. This chapter provides detailed insights into the market which derives the market trends, changing phases of investments, scope of profit potential, and helps to take appropriate business decisions. The chapter on competitive analysis includes the profiling of leading companies in the global market to map the leading companies and their focus of interest in the market.
Global Growth Hormone market Competitive Analysis:
Key players in the Global Growth Hormone market are Novo Nordisk A/S; Pfizer, Inc.; Eli Lilly and Company; Sandoz International GmbH (Novartis AG); Merck KGaA; Genentech, Inc. (Roche); Ferring Pharmaceuticals; Teva Pharmaceutical Industries, Ltd; and Ipsen among other players.
Segmentation Analysis:
Growth Hormone Market, By Route of Administration
· Intravenous
· Subcutaneous
· Intramuscular
· Oral
Growth Hormone Market, By Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
· Clinics
Growth Hormone Market, By Indication
· Growth Hormone Deficiency
· Turner Syndrome
· Idiopathic Short Stature
· Prader-Willi Syndrome
· Other
*All our reports are customizable as per customer requirements
This study forecasts revenue and volume growth at global, regional, and country levels from 2018 to 2029. The global Growth Hormone market is distributed on the basis of the below-mentioned segments:
Global Growth Hormone market, By Region:
The Global Growth Hormone Market is expected to reach USD 5,800 Million by 2029, growing at a 7.60% CAGR between 2022 and 2029. The global market is being bolstered by a surge in initiatives being undertaken by government bodies as well as private firms to raise public awareness about GH deficiencies and growth hormone treatment, which could result in significant market growth. Furthermore, Norditropin has established itself as a leading brand in the global human growth hormone market.
When it comes to rare diseases like growth disorders, raising awareness is critical. If there is a lack of awareness, it is more likely to go unnoticed and go undiagnosed. There is a scarcity of research on the fundamental causes of growth problems and their progression among growth disorders. Most underdeveloped and developing countries have long had these conditions misdiagnosed or undiagnosed. However, the situation has shifted in recent decades. Several awareness initiatives have been launched to raise awareness about the development of children.
Report Includes
An overview of the global Growth Hormone market, and related technologies and developments. Analyses of global market trends, with historical data from 2018, 2023, and 2020 estimates and projections of CAGRs through 2029. It also includes breakdowns of the overall Growth Hormone market along with various segments, and by geographic region. Analysis of the stakeholder value chain in the Growth Hormone market and comprehensive profiles of leading companies in the industry
Report Scope
| Report Metric | Details |
| Market size available for years | 2022–2029 |
| Base year considered | 2021 |
| Forecast period | 2022–2029 |
| Forecast unit | Value (USD Million) |
| Segments covered | Route of Administration, Distribution Channel, Indication, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Novo Nordisk A/S; Pfizer, Inc.; Eli Lilly and Company; Sandoz International GmbH (Novartis AG); Merck KGaA; Genentech, Inc. (Roche); Ferring Pharmaceuticals; Teva Pharmaceutical Industries, Ltd; and Ipsen |
Human Growth Hormone Market COVID-19 Analysis:
The COVID-19 outbreak has had a negative impact on the market as well. Following the World Health Organization's designation of COVID-19 as a pandemic, countries all over the world enacted state-wide lockdowns to enforce social separation as a preventative measure. This caused disruption, limitations, problems, and changes in every industry sector. Similarly, the pandemic affected the Growth Hormone industry.
Following the COVID-19 outbreak, the emphasis has shifted to the rapid development of affordable and effective drugs, with the pandemic shedding light on healthcare disparities. The demand for real-world evidence has increased significantly due to the accelerated drug development rate, with major companies now opting for remote monitoring as well as source document verification (SDV), ensuring that patients can benefit despite the novel coronavirus and the resulting lockdown. While SARS-CoV-2 is the focus of healthcare, growth hormone deficiency is still a major concern around the world. As a result, research is being conducted to better understand the significance of growth hormone drugs and to broaden their application scope. In the post-pandemic era, growth in the pediatric growth hormone market size has also been favorable.
The report forecasts the size of the Growth Hormone market for components from 2022 through 2029
The Executive Summary provides a snapshot of the key findings of the report. The introduction chapter includes the research scope, market segmentation, research methodology, and definitions and assumptions. It involves extremely rigorous scientific methods, tools, and techniques to estimate the market size. Exhaustive secondary research is being carried out to collect information related to the market, the parent market, and the peer market. Primary research is undertaken to validate the assumptions, findings, and sizing with the industry experts professionals across the value chain of the market. Both top-down and bottom-up approaches are employed to estimate the complete market size.
The chapter on market dynamics includes market drivers, restraints, and opportunities which helps familiarise with market potential and upcoming opportunities. The chapter on key insights includes emerging trends from major countries, the latest technological advancement, regulatory landscape, SWOT analysis, and Porter five forces analysis. This chapter provides detailed insights into the market which derives the market trends, changing phases of investments, scope of profit potential, and helps to take appropriate business decisions. The chapter on competitive analysis includes the profiling of leading companies in the global market to map the leading companies and their focus of interest in the market.
Global Growth Hormone market Competitive Analysis:
Key players in the Global Growth Hormone market are Novo Nordisk A/S; Pfizer, Inc.; Eli Lilly and Company; Sandoz International GmbH (Novartis AG); Merck KGaA; Genentech, Inc. (Roche); Ferring Pharmaceuticals; Teva Pharmaceutical Industries, Ltd; and Ipsen among other players.
Segmentation Analysis:
Growth Hormone Market, By Route of Administration
· Intravenous
· Subcutaneous
· Intramuscular
· Oral
Growth Hormone Market, By Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
· Clinics
Growth Hormone Market, By Indication
· Growth Hormone Deficiency
· Turner Syndrome
· Idiopathic Short Stature
· Prader-Willi Syndrome
· Other
*All our reports are customizable as per customer requirements
This study forecasts revenue and volume growth at global, regional, and country levels from 2018 to 2029. The global Growth Hormone market is distributed on the basis of the below-mentioned segments:
Global Growth Hormone market, By Region:
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Growth Hormone MARKET STUDY GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2020-2027
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Segment 1
- 5.2.1. Sub-Segment 1
- 5.2.2. Sub-Segment 2
- 5.3. Market Analysis, Insights and Forecast – By Segment 2
- 5.3.1. Sub-Segment 1
- 5.3.2. Sub-Segment 2
- 5.3.3. Sub-Segment 3
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Segment 3
- 5.4.1. Sub-Segment 1
- 5.4.2. Sub-Segment 2
- 5.4.3. Sub-Segment 3
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Latin America
- 5.5.3. Europe
- 5.5.4. Asia Pacific
- 5.5.5. Middle East and Africa
6. North America Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Segment 1
- 6.2.1. Sub-Segment 1
- 6.2.2. Sub-Segment 2
- 6.3. Market Analysis, Insights and Forecast – By Segment 2
- 6.3.1. Sub-Segment 1
- 6.3.2. Sub-Segment 2
- 6.3.3. Sub-Segment 3
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Segment 3
- 6.4.1. Sub-Segment 1
- 6.4.2. Sub-Segment 2
- 6.4.3. Sub-Segment 3
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Latin America Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Segment 1
- 7.2.1. Sub-Segment 1
- 7.2.2. Sub-Segment 2
- 7.3. Market Analysis, Insights and Forecast – By Segment 2
- 7.3.1. Sub-Segment 1
- 7.3.2. Sub-Segment 2
- 7.3.3. Sub-Segment 3
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Segment 3
- 7.4.1. Sub-Segment 1
- 7.4.2. Sub-Segment 2
- 7.4.3. Sub-Segment 3
- 7.4.4. Others
- 7.5. Insights and Forecast – By Country
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America
8. Europe Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Segment 1
- 8.2.1. Sub-Segment 1
- 8.2.2. Sub-Segment 2
- 8.3. Market Analysis, Insights and Forecast – By Segment 2
- 8.3.1. Sub-Segment 1
- 8.3.2. Sub-Segment 2
- 8.3.3. Sub-Segment 3
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Segment 3
- 8.4.1. Sub-Segment 1
- 8.4.2. Sub-Segment 2
- 8.4.3. Sub-Segment 3
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. UK
- 8.5.2. Germany
- 8.5.3. France
- 8.5.4. Italy
- 8.5.5. Spain
- 8.5.6. Russia
- 8.5.7. Rest of Europe
9. Asia Pacific Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Segment 1
- 9.2.1. Sub-Segment 1
- 9.2.2. Sub-Segment 2
- 9.3. Market Analysis, Insights and Forecast – By Segment 2
- 9.3.1. Sub-Segment 1
- 9.3.2. Sub-Segment 2
- 9.3.3. Sub-Segment 3
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Segment 3
- 9.4.1. Sub-Segment 1
- 9.4.2. Sub-Segment 2
- 9.4.3. Sub-Segment 3
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. China
- 9.5.2. India
- 9.5.3. Japan
- 9.5.4. Australia
- 9.5.5. South East Asia
- 9.5.6. Rest of Asia Pacific
10. Middle East & Africa Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Segment 1
- 10.2.1. Sub-Segment 1
- 10.2.2. Sub-Segment 2
- 10.3. Market Analysis, Insights and Forecast – By Segment 2
- 10.3.1. Sub-Segment 1
- 10.3.2. Sub-Segment 2
- 10.3.3. Sub-Segment 3
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast – By Segment 3
- 10.4.1. Sub-Segment 1
- 10.4.2. Sub-Segment 2
- 10.4.3. Sub-Segment 3
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast – By Country
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.3.1. Company 1
- 11.3.1.1. Business Overview
- 11.3.1.2. Segment 1 & Service Offering
- 11.3.1.3. Overall Revenue
- 11.3.1.4. Geographic Presence
- 11.3.1.5. Recent Development
- 11.3.2. Company 2
- 11.3.3. Company 3
- 11.3.4. Company 4
- 11.3.5. Company 5
- 11.3.6. Company 6
- 11.3.7. Company 7
- 11.3.8. Company 8
- 11.3.9. Company 9
- 11.3.10. Company 10
- 11.3.11. Company 11
- 11.3.12. Company 12
- 11.3.1. Company 1
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
